https://pharmadog.xyz/news/400006 pharmadog en 2026-09-13T08:05:00.000Z GE HealthCare eyes $1 billion purchase of radiopharmaceutical developer Sofie Biosciences https://pharmadog.xyz/news/400991 pharmadog en 2026-09-13T04:00:00.000Z Centric Compounding recalls Glutathione, Myer’s Cocktail and Tri-Immune Boost injectables over elevated endotoxin levels https://pharmadog.xyz/news/398267 pharmadog en 2026-09-13T01:46:49.000Z Akeso and Summit report survival advantage for PD-1xVEGF combo over Keytruda https://pharmadog.xyz/news/395471 pharmadog en 2026-09-12T10:00:51.000Z Novartis encounters setbacks while AI firm Anthropic searches for a dealmaker https://pharmadog.xyz/news/395023 pharmadog en 2026-09-12T07:09:28.000Z AstraZeneca's breast cancer pill camizestrant fails to improve progression-free survival in pivotal SERENA-4 trial https://pharmadog.xyz/news/393831 pharmadog en 2026-09-11T23:30:21.000Z FDA approves Isembyld, first therapy to target muscle loss in SMA patients